Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ID: DRG0IQWFE)
| ADC Name |
Enoblituzumab-ADC-Tb1-20
|
|||||
|---|---|---|---|---|---|---|
| Synonyms |
Enoblituzumab ADC Tb1 20
Click to Show/Hide
|
|||||
| Organization |
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
|
|||||
| Drug Status |
Investigative
|
|||||
| Drug-to-Antibody Ratio |
2-8
|
|||||
| Structure |
|
|||||
| Antibody Name |
Enoblituzumab
|
Antibody Info | ||||
| Antigen Name |
CD276 antigen (CD276)
|
Antigen Info | ||||
| Payload Name |
Enoblituzumab-ADC-Tb1-20 payload
|
|||||
| Linker Name |
Enoblituzumab-ADC-Tb1-20 linker
|
|||||